Zai Lab Limited (ZLAB)
(Delayed Data from NSDQ)
$15.74 USD
+0.08 (0.51%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $15.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Income Statements
Fiscal Year end for Zai Lab Limited Unsponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 267 | 215 | 144 | 49 | 13 |
Cost Of Goods | 96 | 74 | 52 | 17 | 4 |
Gross Profit | 171 | 141 | 92 | 32 | 9 |
Selling & Adminstrative & Depr. & Amort Expenses | 537 | 545 | 792 | 334 | 212 |
Income After Depreciation & Amortization | -367 | -404 | -700 | -302 | -203 |
Non-Operating Income | 32 | -39 | -3 | 34 | 9 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -335 | -443 | -703 | -268 | -194 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | -1 | -1 | -1 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -335 | -443 | -704 | -269 | -195 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -335 | -443 | -704 | -269 | -195 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -361 | -399 | -694 | -297 | -200 |
Depreciation & Amortization (Cash Flow) | 6 | 6 | 6 | 4 | 3 |
Income After Depreciation & Amortization | -367 | -404 | -700 | -302 | -203 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 96.64 | 95.81 | 92.99 | 77.67 | 64.37 |
Diluted EPS Before Non-Recurring Items | -3.50 | -4.63 | -7.58 | -3.46 | -3.03 |
Diluted Net EPS (GAAP) | -3.46 | -4.63 | -7.58 | -3.46 | -3.03 |
Fiscal Year end for Zai Lab Limited Unsponsored ADR falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 65.83 | 69.23 | 68.86 | 62.80 |
Cost Of Goods | NA | 25.24 | 25.48 | 23.76 | 21.34 |
Gross Profit | NA | 40.59 | 43.75 | 45.10 | 41.46 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 164.58 | 127.32 | 134.60 | 110.98 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -123.99 | -83.57 | -89.50 | -69.52 |
Non-Operating Income | NA | 28.55 | 14.42 | -31.39 | 20.38 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -95.43 | -69.15 | -120.90 | -49.14 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -95.43 | -69.15 | -120.90 | -49.14 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -95.43 | -69.15 | -120.90 | -49.14 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 96.98 | 96.88 | 96.48 | 96.15 |
Diluted EPS Before Non-Recurring Items | NA | -0.98 | -0.71 | -1.25 | -0.51 |
Diluted Net EPS (GAAP) | NA | -0.99 | -0.71 | -1.25 | -0.51 |